PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Thoracic Cancer |
Online Access: | https://doi.org/10.1111/1759-7714.13972 |